Back to today’s briefing

Story perspectives

Pfizer's CEO Slams $766M Cut for Moderna Vaccine

6/3/2025

49 7

Summary

Story summary

Pfizer CEO Albert Bourla voiced strong disapproval of the U.S. government's $766 million funding cut for Moderna's bird flu vaccine, highlighting its scientific merit. He underscored the critical role of mRNA vaccines in combating serious illnesses, as fears mount over the H5N1 bird flu strain that has already impacted at least 70 individuals in the U.S.

1 of 1

Story summary

Pfizer CEO Albert Bourla voiced strong disapproval of the U.S. government's $766 million funding cut for Moderna's bird flu vaccine, highlighting its scientific merit. He underscored the critical role of mRNA vaccines in combating serious illnesses, as fears mount over the H5N1 bird flu strain that has already impacted at least 70 individuals in the U.S.